Cleared Traditional

K103792 - BARCO MAMMO TOMOSYNTHESIS

K103792 is an FDA 510(k) clearance for BARCO MAMMO TOMOSYNTHESIS, manufactured by Barco N.V.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K103792 · Barco N.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
67d
Days
Class 2
Risk

K103792 is an FDA 510(k) clearance for the BARCO MAMMO TOMOSYNTHESIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Barco N.V. (8500 Kortrijk, BE). The FDA issued a Cleared decision on March 4, 2011 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Barco N.V. devices

FDA 510(k) Submission Details - K103792

510(k) Number K103792 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2010
Decision Date March 04, 2011
Days to Decision 67 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 107d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1899
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K103792.
THORACIC VCAR
K103480 · Ge Medical Systems, LLC · Mar 2011
VIEWPOINT 6
K103458 · Ge Healthcare · Mar 2011
SYNAPSE 3D CEREBRAL ANALYSIS
K103687 · Fujifilm Medical System U.S.A., Inc. · Mar 2011
AXIS PACS, HMS PACS
K103679 · Axis Health Care, LLC · Mar 2011
MIM 5.2 (BRACHY)
K103576 · Mim Software, Inc. · Feb 2011
VISUALIZE: VASCULAR
K103761 · The Medipattern Corporation · Feb 2011